Results 151 to 160 of about 224,992 (367)

Evaluation of a Novel Immunoassay for Quantification of C1q for Clinical Diagnostic Use

open access: yesFrontiers in Immunology, 2019
Objectives: C1q is a valuable biomarker of disease activity in systemic lupus erythematosus (SLE). The “gold standard” assay, rocket immunoelectrophoresis (RIE), is time-consuming, and thus a shift to soluble immune precipitation techniques such as ...
Kerstin Sandholm   +10 more
doaj   +1 more source

Clinical effects of combination therapy with continuous renal replacement therapy and continuous intravenous sodium infusion therapy

open access: yesTherapeutic Apheresis and Dialysis, EarlyView.
Abstract Introduction This single‐center retrospective study investigated the clinical effects of combination therapy involving continuous renal replacement therapy (CRRT) and continuous intravenous sodium infusion therapy (cIVNa) in critically ill patients with prerenal acute kidney injury (AKI) who were expected to experience insufficient plasma ...
Akinori Yamaguchi   +5 more
wiley   +1 more source

Clinicopathologic Features of Membranous-Like Glomerulopathy With Masked IgG Kappa Deposits

open access: yesKidney International Reports, 2016
Ig deposits identified on renal biopsy samples by paraffin immunofluorescence that show negative staining by routine immunofluorescence on frozen tissue have become known as “masked” deposits.
C.P. Larsen   +4 more
doaj   +1 more source

Biomarkers of IgA vasculitis nephritis in children

open access: yesPLoS ONE, 2017
Henoch–Schönlein purpura is a systemic vasculitis characterized by IgA deposits, which target the skin, joints, and kidneys, among other organs. In children, prognosis is often good but little is known about biomarkers of pediatric nephritis.
É. Pillebout   +9 more
semanticscholar   +1 more source

Urticarial Plaques With Vesicles in a Young Hispanic Woman

open access: yes
JEADV Clinical Practice, EarlyView.
Valeria Olvera‐Rodríguez   +6 more
wiley   +1 more source

Real‐World Survival Outcomes of Patients With High PD‐L1 Advanced NSCLC Who Received Chemoimmunotherapy Versus Immunotherapy

open access: yesAsia-Pacific Journal of Clinical Oncology, EarlyView.
Are two drugs better than one in advanced NSCLC? ABSTRACT Background Randomized studies have demonstrated superior overall survival (OS) of pembrolizumab (pembro), both alone and in combination with chemotherapy (chemo) over chemo alone in patients with programmed cell death ligand‐1 (PD‐L1) ≥ 50% advanced non–small cell lung cancer (NSCLC).
Junipearl Cheng   +5 more
wiley   +1 more source

Intracapillary immune complexes recruit and activate slan-expressing CD16+ monocytes in human lupus nephritis.

open access: yesJCI Insight, 2018
Lupus nephritis is a major cause of morbidity in patients with systemic lupus erythematosus. Among the different types of lupus nephritis, intracapillary immune complex (IC) deposition and accumulation of monocytes are hallmarks of lupus nephritis class ...
F. Olaru   +9 more
semanticscholar   +1 more source

Basophil Activation Test: Bridging Allergy and Oncology for Diagnostic, Therapeutic and Prognostic Applications in AllergoOncology: An EAACI Position Paper

open access: yesAllergy, EarlyView.
ABSTRACT The basophil activation test (BAT) is gaining increasing relevance as an ex vivo functional assay in allergy to evaluate IgE‐mediated hypersensitivity reactions to food allergens, venoms, and drugs and to monitor tolerance induction. Establishing universal standard operating protocols has been difficult, due to several challenges including ...
Mariona Pascal   +18 more
wiley   +1 more source

Home - About - Disclaimer - Privacy